PS PeptideSuppliers.org The peptide supplier database
Peptides · Thymosin beta-4 related peptide

TB-500: a research guide to a name that means more than one molecule

A research peptide sold under the name of its parent protein, thymosin beta-4. What a vendor means by TB-500 is not standardized.

TB-500 cover illustration

Research-use-only material. This guide explains what the name TB-500 refers to and how to evaluate documentation. It contains no dosing, protocols or health claims. Supplier links below are affiliate links; details are near the end.

First, which molecule?

Most compounds in this directory have a single, settled definition. TB-500 does not, and that is the most important thing to understand before you compare a single listing. The name is commonly used for a synthetic version of thymosin beta-4, a small protein of 43 amino acids that cells make naturally and that was first isolated from calf thymus tissue in the 1960s. But "TB-500" is a trade-style label, not a chemical name, and over the years it has been attached to at least two different things.

The first is the full-length protein, with a mass close to 4,963 daltons. The second is a short stretch from the middle of thymosin beta-4: seven residues, Leu-Lys-Lys-Thr-Glu-Thr-Gln, usually with an acetyl cap on the front. That region, residues 17 to 23, is the part of the protein associated with actin binding in the cell-biology literature, and it weighs under 1,000 daltons. Anti-doping scientists who built detection methods for TB-500 in the 2010s described it as that fragment. Some suppliers sell something closer to the full protein. Some do not say.

Bar diagram showing the 43-amino-acid thymosin beta-4 protein with the short 17 to 23 fragment highlighted, and the seven-residue fragment drawn below
Thymosin beta-4 and the short fragment often meant by "TB-500." Illustration by PeptideSuppliers.org.

Why does that matter? Because two vials both labeled "TB-500, 10 mg" can contain entirely different numbers of molecules and entirely different compounds. A seven-residue peptide and a 43-residue protein are different products with different synthesis difficulty, different stability, and different costs. Comparing prices across the two is meaningless, and neither can be assumed to behave like the other in an experiment.

What the research literature describes

Thymosin beta-4 itself is well studied in cell biology. It binds monomeric actin, helps regulate how cells assemble their internal scaffolding, and has been examined in work on cell migration, wound models and cardiac tissue in animals. A small number of early clinical studies explored the full protein in specific conditions. That is genuine science, but it concerns the natural protein or tightly characterized pharmaceutical preparations.

The connection to "TB-500" the research chemical is looser. Much of what circulates online about TB-500 borrows results from thymosin beta-4 papers and applies them to whatever vial is on the market. That is a leap. A fragment is not guaranteed to reproduce the behavior of the protein it came from, and results from rodents or cultured cells do not establish anything about people. If you are reading a paper, check which molecule it actually used before assuming it applies to the product you are evaluating.

For regulatory context: TB-500 and thymosin beta-4 appear on the World Anti-Doping Agency's prohibited list, which tells you the compound is taken seriously enough that detection tests exist. It is not an approved medicine, and this site does not offer advice on using it.

Two synthesis problems, not one

The two candidate molecules fail in different ways, which affects what you should look for on a certificate of analysis.

The seven-residue fragment is easy to make well. Seven couplings on a resin is a modest job, and a competent synthesis yields a clean product. Where suppliers go wrong is in identity and labeling: leaving off the acetyl cap, mislabeling the mass, or stating a fill amount that includes salt weight. On a COA you should see a mass near the expected value for the capped fragment, and a clean single HPLC peak.

The full-length protein is a very different challenge. At 43 residues, chemical synthesis accumulates errors: every coupling step has a small failure rate, and over 43 steps the compounding matters. Truncated sequences and deletion peptides are common, and they co-elute near the main peak. A trace that looks fine at a glance can hide a lot of near-identical contamination. Mass spectrometry matters more here, and a report that only quotes a purity figure with no spectrum should be treated cautiously. Recombinant production is another route to the full protein, and it brings its own questions about host-cell residues.

What a useful TB-500 COA contains

Stated identityThe report should say which sequence it tested: the fragment, or the full-length protein. If it says only "TB-500," ask.
Observed massRoughly 889 Da for the acetylated seven-residue fragment, or about 4,963 Da for the full protein. Anything else needs explaining.
HPLC traceThe chart, not only a percentage. Shoulders on the main peak are a warning, especially for the long form.
Batch detailsLot number matching your vial, test date, and the name of the lab.
ContentA net-peptide figure if available. Counter-ion and water can account for a meaningful part of the label weight.

If the supplier will not tell you which molecule they mean, that alone is useful information. A supplier that answers precisely, and whose COA matches its answer, is demonstrating the habit of care that matters most in this market.

Questions to put to a supplier

Because the product definition is loose, a short email can tell you more than the listing page. Ask which sequence the product is, whether the fragment carries the acetyl cap, what mass the lab observed, and whether the COA you are shown belongs to the batch you will receive. Ask how long the batch has been in stock and how it is shipped. A reply that is specific, prompt and consistent with the paperwork is a good sign; a reply that restates the marketing copy, or avoids naming the molecule, is a poor one. We apply the same test in our supplier reviews, and it is cheap for you to apply before an order rather than after.

Pairing with BPC-157 in listings

You will see TB-500 sold on its own and in blends with BPC-157, often as a single vial with a combined label. Blends add a layer of uncertainty because the COA has to cover two components in stated proportions, and some reports show only one. When comparing a blend to two separate vials, check that each component has its own identity confirmation and that the milligram split is stated. Our BPC-157 guide covers the other half of the usual pairing.

Where to find it

Three suppliers in our directory list TB-500. I have not ordered from them for this page; the summary reflects their public listings. Please verify the molecule and the batch documentation before relying on any of them.

Iron Peptides lists a 10 mg TB-500 vial. Code IRONMAN gives 10% off. See the Iron Peptides review; Iron is also a sponsored listing on this site.

Next Gen Peps carries TB-500 under the handle "tb500" and also sells a BPC-157 and TB-500 blend. See our Next Gen Peps review.

Vortex Research lists TB-500 as a single vial and runs the PEPPERS code, advertised at 30% off. Not yet reviewed here.

All three links are affiliate links. PeptideSuppliers.org may earn a commission if you purchase, at no cost to you. This does not influence our ratings, and the suppliers above appear in alphabetical order. Read the full disclosure.

Common questions

Is TB-500 the same as thymosin beta-4?

Not reliably. Thymosin beta-4 is the 43-amino-acid natural protein; TB-500 is a label that vendors apply to a synthetic analog or fragment.

Why would a seller leave the molecule undefined?

Sometimes laziness, sometimes the convenience of selling a catalog name rather than a defined structure. Either way, it is a reason to ask before buying.

Where does the 17 to 23 region come from?

It is the actin-binding stretch of thymosin beta-4 in the cell-biology literature, and was the target of published anti-doping detection methods.

For another small, copper-binding peptide with a very different literature, see GHK-Cu. To compare every supplier we track, use the supplier database.

For laboratory research use only. Not medical advice; no claims about safety, legality or fitness for any use. See the medical disclaimer.